Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Tuberculosis in asymptomatic HIV-infected adults with abnormal chest radiographs screened for tuberculosis prevention.

Agizew TB, Arwady MA, Yoon JC, Nyirenda S, Mosimaneotsile B, Tedla Z, Motsamai O, Kilmarx PH, Wells CD, Samandari T.

Int J Tuberc Lung Dis. 2010 Jan;14(1):45-51.

PMID:
20003694
2.

Association of chest radiographic abnormalities with tuberculosis disease in asymptomatic HIV-infected adults.

Agizew T, Bachhuber MA, Nyirenda S, Makwaruzi VZ, Tedla Z, Tallaksen RJ, Parker JE, Mboya JJ, Samandari T.

Int J Tuberc Lung Dis. 2010 Mar;14(3):324-31.

PMID:
20132624
3.

Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.

Kabali C, von Reyn CF, Brooks DR, Waddell R, Mtei L, Bakari M, Matee M, Pallangyo K, Arbeit RD, Horsburgh CR Jr.

Int J Tuberc Lung Dis. 2011 Nov;15(11):1515-21, i. doi: 10.5588/ijtld.10.0788.

PMID:
22008766
4.

Isoniazid tuberculosis preventive therapy in HIV-infected adults accessing antiretroviral therapy: a Botswana Experience, 2004-2006.

Mosimaneotsile B, Mathoma A, Chengeta B, Nyirenda S, Agizew TB, Tedla Z, Motsamai OI, Kilmarx PH, Wells CD, Samandari T.

J Acquir Immune Defic Syndr. 2010 May 1;54(1):71-7. doi: 10.1097/QAI.0b013e3181c3cbf0.

PMID:
19934764
5.

Anti-tuberculosis treatment outcomes in HIV-infected adults exposed to isoniazid preventive therapy in Botswana.

Sibanda T, Tedla Z, Nyirenda S, Agizew T, Marape M, Miranda AG, Reuter H, Johnson JL, Samandari T.

Int J Tuberc Lung Dis. 2013 Feb;17(2):178-85. doi: 10.5588/ijtld.12.0314.

PMID:
23317952
6.

Treatment of latent tuberculosis infection in HIV infected persons.

Akolo C, Adetifa I, Shepperd S, Volmink J.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD000171. doi: 10.1002/14651858.CD000171.pub3. Review.

PMID:
20091503
7.

Implementation and evaluation of an isoniazid preventive therapy pilot program among HIV-infected patients in Vietnam, 2008-2010.

Trinh TT, Han DT, Bloss E, Le TH, Vu TT, Mai AH, Nguyen NV, Nguyen LT, Dinh SN, Whitehead S.

Trans R Soc Trop Med Hyg. 2015 Oct;109(10):653-9. doi: 10.1093/trstmh/trv074.

8.

Systematic review of TST responses in people living with HIV in under-resourced settings: implications for isoniazid preventive therapy.

Kerkhoff AD, Kranzer K, Samandari T, Nakiyingi-Miiro J, Whalen CC, Harries AD, Lawn SD.

PLoS One. 2012;7(11):e49928. doi: 10.1371/journal.pone.0049928. Epub 2012 Nov 27. Review. Erratum in: PLoS One. 2013;8(5). doi: 10.1371/annotation/e4800fcf-c58a-4d5a-a90a-bb6aed93454a.

9.

Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana.

Tedla Z, Nyirenda S, Peeler C, Agizew T, Sibanda T, Motsamai O, Vernon A, Wells CD, Samandari T.

Am J Respir Crit Care Med. 2010 Jul 15;182(2):278-85. doi: 10.1164/rccm.200911-1783OC. Epub 2010 Apr 8.

PMID:
20378730
10.

Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program.

Perlman DC, Gourevitch MN, Trinh C, Salomon N, Horn L, Des Jarlais DC.

J Urban Health. 2001 Sep;78(3):550-67.

11.

Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil.

Saraceni V, Pacheco AG, Golub JE, Vellozo V, King BS, Cavalcante SC, Eldred L, Chaisson RE, Durovni B.

Braz J Infect Dis. 2011 May-Jun;15(3):249-52.

12.

Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials.

Ayele HT, Mourik MS, Debray TP, Bonten MJ.

PLoS One. 2015 Nov 9;10(11):e0142290. doi: 10.1371/journal.pone.0142290. eCollection 2015. Review.

14.

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpé JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouamé A, Inwoley A, Toni TD, Ahiboh H, Kabran M, Rabe C, Sidibé B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouamé E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundzé S, Hawerlander D, Ani A, Dembélé F, Koné F, Guéhi C, Kanga C, Koule S, Séri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan-Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semdé C, Kouame A, Massumbuko JM, Chêne G, Dosso M, Domoua SK, N'Dri-Yoman T, Salamon R, Eholié SP, Anglaret X.

N Engl J Med. 2015 Aug 27;373(9):808-22. doi: 10.1056/NEJMoa1507198. Epub 2015 Jul 20.

15.

High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening.

Oni T, Burke R, Tsekela R, Bangani N, Seldon R, Gideon HP, Wood K, Wilkinson KA, Ottenhoff TH, Wilkinson RJ.

Thorax. 2011 Aug;66(8):669-73. doi: 10.1136/thx.2011.160168. Epub 2011 May 31.

16.

Primary and secondary tuberculosis preventive treatment in HIV clinics: simulating alternative strategies.

Basu S, Maru D, Poolman E, Galvani A.

Int J Tuberc Lung Dis. 2009 May;13(5):652-8.

PMID:
19383201
17.

Costs and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana.

Samandari T, Bishai D, Luteijn M, Mosimaneotsile B, Motsamai O, Postma M, Hubben G.

Am J Respir Crit Care Med. 2011 Apr 15;183(8):1103-11. doi: 10.1164/rccm.201004-0620OC. Epub 2010 Dec 10.

18.

Tuberculosis screening and isoniazid preventive therapy implementation: a Brazilian experience.

Swaminathan S, Chandrasekaran P.

Expert Rev Anti Infect Ther. 2014 Mar;12(3):289-92. doi: 10.1586/14787210.2014.880338. Epub 2014 Jan 23.

PMID:
24455973
19.

6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial.

Samandari T, Agizew TB, Nyirenda S, Tedla Z, Sibanda T, Shang N, Mosimaneotsile B, Motsamai OI, Bozeman L, Davis MK, Talbot EA, Moeti TL, Moffat HJ, Kilmarx PH, Castro KG, Wells CD.

Lancet. 2011 May 7;377(9777):1588-98. doi: 10.1016/S0140-6736(11)60204-3. Epub 2011 Apr 12.

PMID:
21492926
20.

Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.

Aisu T, Raviglione MC, van Praag E, Eriki P, Narain JP, Barugahare L, Tembo G, McFarland D, Engwau FA.

AIDS. 1995 Mar;9(3):267-73.

PMID:
7755915

Supplemental Content

Support Center